Published in Diabet Med on July 01, 1991
Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest (1992) 2.26
Protective role of Scoparia dulcis plant extract on brain antioxidant status and lipidperoxidation in STZ diabetic male Wistar rats. BMC Complement Altern Med (2004) 1.26
The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ Med J (2012) 1.17
Diabetes, oxidative stress and physical exercise. J Sports Sci Med (2002) 1.11
The As and Ds of stress: metabolic, morphological and behavioral consequences. Eur J Pharmacol (2008) 0.98
Oxidative stress as a mechanism of added sugar-induced cardiovascular disease. Int J Angiol (2014) 0.85
Diabetic nephropathy: Treatment with phosphodiesterase type 5 inhibitors. World J Diabetes (2013) 0.82
Electron impact mass spectroscopic studies on mouse retinal fatty acids: effect of diabetes. Ophthalmic Res (2009) 0.81
Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes. Open Heart (2015) 0.78
Haptoglobin: A major susceptibility gene for diabetic vascular complications. Exp Clin Cardiol (2002) 0.78
2β-hydroxybetulinic acid 3β-caprylate: an active principle from Euryale Ferox Salisb. seeds with antidiabetic, antioxidant, pancreas & hepatoprotective potential in streptozotocin induced diabetic rats. J Food Sci Technol (2014) 0.77
Effects of the SOD mimic nitroxide 3-carbamoyl-PROXYL on oxidative stress markers and endothelial dysfunction in streptozotocin-induced diabetic rats. Exp Clin Cardiol (2002) 0.75
Efficacy and safety of intravenous midazolam and ketamine as sedation for therapeutic and diagnostic procedures in children. Pediatrics (1997) 15.08
Impairment of insulin secretion in man by nifedipine. Eur J Clin Pharmacol (1980) 2.22
The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia (2000) 1.86
Oxidative stress and insulin action: is there a relationship? Diabetologia (1996) 1.86
Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord (1998) 1.76
The intrathymic expression of insulin-related genes: implications for pathophysiology and prevention of Type 1 diabetes. Diabetes Metab Rev (1998) 1.58
The metabolic syndrome: a cause of sexual dysfunction in women. Int J Impot Res (2005) 1.50
Elevated plasma fatty acid concentrations prolong cardiac repolarization in healthy subjects. Am J Clin Nutr (2001) 1.49
Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J Thromb Haemost (2004) 1.48
Association of body weight with sexual function in women. Int J Impot Res (2007) 1.43
Pregnancy as environmental factor precipitating IDDM. Diabetes Care (1989) 1.43
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA (1999) 1.42
Protein C deficiency in insulin-dependent diabetes: a hyperglycemia-related phenomenon. Thromb Haemost (1990) 1.40
Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia (2002) 1.38
Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res (2010) 1.38
Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008. Nutr Metab Cardiovasc Dis (2010) 1.36
Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation (2000) 1.27
No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients. J Clin Endocrinol Metab (2000) 1.25
Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest (2001) 1.23
Adherence to a Mediterranean diet and glycaemic control in Type 2 diabetes mellitus. Diabet Med (2009) 1.18
Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency. J Clin Endocrinol Metab (1991) 1.15
Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol (1998) 1.15
Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients. Diabetes Obes Metab (2011) 1.14
Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug? Ann Intern Med (1990) 1.14
Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr (1993) 1.14
Dipeptidyl peptidase-4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials. Diabetes Obes Metab (2011) 1.14
Effect of acute hyperglycaemia, long-term glycaemic control and insulin on endothelial dysfunction and inflammation in Type 1 diabetic patients with different characteristics. Diabet Med (2010) 1.13
Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care (1991) 1.12
Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications. Diabetes Metab (1996) 1.12
Obesity, the metabolic syndrome, and sexual dysfunction. Int J Impot Res (2005) 1.11
Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care (2000) 1.10
Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men. J Endocrinol Invest (2004) 1.09
Impaired glucose metabolism in heroin and methadone users. Horm Metab Res (1987) 1.07
Acute hyperglycemia and autonomic function. Diabetes Care (2001) 1.07
Severe/extreme obesity: a medical disease requiring a surgical treatment? Acta Clin Belg (1999) 1.06
Influence of acetylsalicylic acid on glucose turnover in normal man. Diabete Metab (1982) 1.06
Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. Am J Physiol (1995) 1.06
Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis. J Endocrinol Invest (2013) 1.04
Erectile and endothelial dysfunction in Type II diabetes: a possible link. Diabetologia (2001) 1.02
Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism (1994) 1.02
Factors controlling gastric-glucagon release. J Clin Invest (1977) 1.02
The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose Level. J Clin Endocrinol Metab (1996) 1.02
The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis (2004) 1.01
Glucose tolerance and hormonal responses in heroin addicts. A possible role for endogenous opiates in the pathogenesis of non-insulin-dependent diabetes. Metabolism (1983) 1.01
Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. Eur J Clin Pharmacol (1993) 1.00
The effect of acetylsalicylic acid on insulin response to glucose and arginine in normal man. Diabetologia (1978) 0.99
Effect of metformin on food intake in obese subjects. Eur J Clin Invest (1998) 0.99
Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes. Diabetologia (1998) 0.98
A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control. Diabetologia (1983) 0.98
High glucose induces ventricular instability and increases vasomotor tone in rats. Diabetologia (2001) 0.98
Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. Am J Physiol (1994) 0.98
Resting metabolic rate and respiratory quotient in human longevity. J Clin Endocrinol Metab (2004) 0.97
Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study. Fertil Steril (1986) 0.96
Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care (1993) 0.96
Obesity and sexual dysfunction, male and female. Int J Impot Res (2008) 0.95
New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med (1992) 0.95
Determinants of erectile dysfunction in type 2 diabetes. Int J Impot Res (2010) 0.94
Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man. Diabetologia (1986) 0.93
Mediterranean diet improves erectile function in subjects with the metabolic syndrome. Int J Impot Res (2006) 0.93
How to measure insulin clearance. Diabetes Metab Rev (1994) 0.92
Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress. Diabetologia (1993) 0.91
Oxidative stress in the metabolic syndrome. J Endocrinol Invest (2006) 0.90
Autonomic dysfunction associates with prolongation of QT intervals and blunted night BP in obese women with visceral obesity. J Endocrinol Invest (2002) 0.90
Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial. Diabetes Obes Metab (2011) 0.90
Insulin action in man. Diabetes Metab (1996) 0.89
Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients. J Clin Endocrinol Metab (1993) 0.89
Advancing age and insulin resistance: new facts about an ancient history. Eur J Clin Invest (1999) 0.89
Abnormal rheologic effects of glyceryl trinitrate in patients with non-insulin-dependent diabetes mellitus and reversal by antioxidants. Ann Intern Med (1995) 0.88
Effects of ingested fructose and infused glucagon on endogenous glucose production in obese NIDDM patients, obese non-diabetic subjects, and healthy subjects. Diabetologia (1996) 0.88
Blood glucose may condition factor VII levels in diabetic and normal subjects. Diabetologia (1988) 0.88
Increased glycosylated haemoglobin A1 in opiate addicts: evidence for a hyperglycaemic effect of morphine. Diabetologia (1982) 0.87
Effect of irbesartan on nitrotyrosine generation in non-hypertensive diabetic patients. Diabetologia (2004) 0.87
Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion. Diabetes Care (1984) 0.87
Glutathione infusion potentiates glucose-induced insulin secretion in aged patients with impaired glucose tolerance. Diabetes Care (1992) 0.87
Endothelial microparticles correlate with erectile dysfunction in diabetic men. Int J Impot Res (2006) 0.87
Acetyl-L-carnitine for symptomatic diabetic neuropathy. Diabetologia (1995) 0.87
Evidence for peripheral impaired glucose handling in patients with connective tissue diseases. Metabolism (1991) 0.87
Obesity, the metabolic syndrome, and sexual dysfunction in men. Clin Pharmacol Ther (2011) 0.87
Morphine, opioid peptides, and pancreatic islet function. Diabetes Care (1984) 0.86
The kallikrein-kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity. Diabetes Metab Res Rev (2004) 0.86
Pharmacokinetic-pharmacodynamic relationships of Acarbose. Clin Pharmacokinet (1996) 0.86
Effect of dog jejunum "glucagon-like immunoreactive material" on adipose tissue metabolism. Horm Metab Res (1969) 0.86
Lifestyle and metabolic approaches to maximizing erectile and vascular health. Int J Impot Res (2011) 0.86
Role of free fatty acids on cardiac autonomic nervous system in noninsulin-dependent diabetic patients: effects of metabolic control. J Clin Endocrinol Metab (2001) 0.86
GLP-1 receptor agonists and HBA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials. Curr Med Res Opin (2011) 0.86